Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2025

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Summary of Stock Options Activity

The following table summarizes the stock option activity for the nine months ended September 30, 2025 (in thousands, except share and per share data):

	Number of Shares			Weighted Average Exercise Price per Share		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2025		3,992,335		$	4.99		6.86	$	19,318
Granted		1,439,255		$	7.81
Exercised		(20,677	)	$	2.37
Forfeited		(67,769	)	$	7.64
Expired		(32,536	)	$	10.78
Outstanding at September 30, 2025		5,310,608		$	5.69		6.95	$	16,469
Exercisable at September 30, 2025		3,083,268		$	2.31		6.07	$	12,332
Vested and expected to vest at September 30, 2025		5,025,926		$	3.74		7.16	$	14,836

Schedule of Weighted-Average Assumptions used in Black-Scholes Option-Pricing Model

The weighted average assumptions used in the Black-Scholes pricing model for stock options granted during the three and nine months ended September 30, 2025 and 2024, were as follows:

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2025			2024			2025			2024
Estimated dividend yield		-	%		-	%		-	%		-	%
Weighted-average expected stock price volatility		36.58	%		36.05	%		36.06	%		35.91	%
Weighted-average risk-free interest rate		4.16	%		3.49	%		4.33	%		4.33	%
Expected average term of options (in years)		6.25			6.25			6.16			6.25
Weighted-average fair value of common stock	$	4.44		$	4.40		$	7.81		$	2.86
Weighted-average fair value per option	$	1.94		$	1.84		$	3.39		$	1.24

Schedule of Restricted Stock Unit Activity

The following table summarizes the restricted stock unit activity for the nine months ended September 30, 2025 (in thousands, except share and per share data):

	Number of Shares			Weighted Average Grant Date Fair Value per Share		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at January 1, 2025		127,611		$	3.47		0.84	$	1,066
Granted		—		$	—
Vested		(82,538	)	$	2.42
Forfeited		—		$	—
Outstanding at September 30, 2025		45,073		$	5.41		0.91	$	279
Vested and expected to vest at September 30, 2025		45,073		$	5.41		0.91	$	279

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense included in the accompanying condensed financial statements was as follows (in thousands):

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2025		2024		2025		2024
Cost of sales	$	29	$	10	$	85	$	89
Research and development		14		18		13		65
Sales and marketing		61		33		166		162
General and administrative		746		699		2,388		2,584
Total stock-based compensation expense	$	850	$	760	$	2,652	$	2,900